Trichomonas vaginalis infection among Iranian general population of women: a systematic review and meta-analysis

Parasitology Research
Hajar Ziaei HezarjaribiMahbobeh Taghavi

Abstract

Trichomonas vaginalis (T. vaginalis) is one of the main causes of vaginitis, prostatitis, and cervicitis all over the world. Little information is available regarding the burden of T. vaginalis infection in Iranian women. This systematic review and meta-analysis were carried out to determine the prevalence of T. vaginalis among general population of Iranian women. Data were systematically collected from 1992 to 2012 in Iran on such electronic databases as PubMed, Google Scholar, Science Direct, Scopus, Web of Science, Magiran, Irandoc, Iran medex, Scientific Information Database (SID), Global Health, and LILACS. Additionally, abstracts of national scientific congresses and dissertations were included. A total of 30 articles attempted to examine 70,373 individuals and reported the prevalence of trichomoniasis from different regions of Iran. The overall prevalence rate of trichomoniasis in Iran was estimated to be 8% (95% confidence interval (CI) = 0.07 to 0.09) with the maximum 38.8% (95% CI = 0.036 to 0.042) and the minimum 0.009% (95% CI = 0.008 to 0.010), respectively. Also, it was found that the prevalence in Central provinces is higher than other ones. In all studies, the average of age was 24.5 with the maximum and the min...Continue Reading

References

Mar 1, 1993·Clinical Obstetrics and Gynecology·P Heine, J A McGregor
Jul 1, 1995·Annals of Epidemiology·Z F ZhangJ L Xu
Jul 15, 1998·Sexually Transmitted Diseases·J ShuterE Y Bellin
Aug 15, 1998·Tropical Medicine & International Health : TM & IH·A M Gülmezoglu, P Garner
Feb 28, 2001·Infectious Diseases in Obstetrics and Gynecology·S R PatelC A Estrada
Nov 11, 2003·Clinical and Diagnostic Laboratory Immunology·G A MillerC F Caceres
Jan 30, 2004·American Journal of Obstetrics and Gynecology·David Soper
Sep 2, 2004·International Journal of STD & AIDS·A GarciaR Correia da Silva
Oct 19, 2004·Clinical Microbiology Reviews·Jane R Schwebke, Donald Burgess
Dec 15, 2004·Clinical Obstetrics and Gynecology·Margaret A Riggs, Mark A Klebanoff
Nov 4, 2006·Journal of Midwifery & Women's Health·Jane Mashburn
Jan 15, 2008·Current Opinion in Infectious Diseases·Victoria J Johnston, David C Mabey
Oct 25, 2008·Bulletin of the World Health Organization·Katharine J LookerGeorge P Schmid
Jul 20, 2010·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·A LeeA Fitzgerald O'Connor
Dec 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Laura H BachmannKimberly A Workowski
Sep 3, 2014·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Angelica E MirandaCharlotte A Gaydos

❮ Previous
Next ❯

Citations

Nov 18, 2015·Parasitology Research·Malihe Nourollahpour ShiadehAli Rostami
Nov 11, 2016·Journal of Parasitology Research·Reza ShafieiFatemeh Mirzaee
Sep 30, 2016·Revista Do Instituto De Medicina Tropical De São Paulo·Cíntia Lima AmbrozioMarcos Marreiro Villela
Jan 18, 2019·Infectious Disorders Drug Targets·Sasan NikpayJahangir Abdi
Nov 24, 2016·Journal of Parasitic Diseases : Official Organ of the Indian Society for Parasitology·Zohreh MomeniAbdolhossein Dalimi
Jul 20, 2021·Reports of Biochemistry & Molecular Biology·Maryam AlikhaniAsad Mirzaei
Feb 20, 2020·Infectious Disorders Drug Targets·Abdollah RafieiMahin Najafian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.